Skip to main content
. 2022 Nov 3;23:354. doi: 10.1186/s12882-022-02991-5

Fig. 2.

Fig. 2

Analysis of disease and immune activity. A Comparison of the immune cell results between control and IgAN patients. B Comparison of the immune-related function results between the two groups. ***, p < 0.001; **, p < 0.01; *, p < 0.05; ns, p > 0.05